Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 1
2009 1
2011 2
2012 3
2013 1
2014 2
2015 6
2016 7
2017 8
2018 3
2019 1
2020 6
2021 5
2022 10
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinoma.
Huang Q, Han Y, Shen E, Feng Z, Peng Y, Gao L, Gao Y, Liu Y, Li W, Liu P, Chen Y, Guo C, Zeng S, Cai C, Shen H. Huang Q, et al. Among authors: guo c. iScience. 2022 Sep 10;26(1):105095. doi: 10.1016/j.isci.2022.105095. eCollection 2023 Jan 20. iScience. 2022. PMID: 36713263 Free PMC article.
PI3Kδ Mediates Fibrosis by Patient-Derived Vitreous.
Liu D, Yan B, Yin Y, Chen F, Guo C, Li Q, Liu J, Pu L, Wu W, Luo J. Liu D, et al. Among authors: guo c. Lab Invest. 2024 Apr;104(4):102026. doi: 10.1016/j.labinv.2024.102026. Epub 2024 Feb 1. Lab Invest. 2024. PMID: 38307209
A comprehensive analysis of the efficacy and safety of COVID-19 vaccines.
Cai C, Peng Y, Shen E, Huang Q, Chen Y, Liu P, Guo C, Feng Z, Gao L, Zhang X, Gao Y, Liu Y, Han Y, Zeng S, Shen H. Cai C, et al. Among authors: guo c. Mol Ther. 2021 Sep 1;29(9):2794-2805. doi: 10.1016/j.ymthe.2021.08.001. Epub 2021 Aug 6. Mol Ther. 2021. PMID: 34365034 Free PMC article.
Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma.
Liu P, Zhu Z, Ma J, Wei L, Han Y, Shen E, Tan X, Chen Y, Cai C, Guo C, Peng Y, Gao Y, Liu Y, Huang Q, Gao L, Li Y, Jiang Z, Wu W, Liu Y, Zeng S, Li W, Feng Z, Shen H. Liu P, et al. Among authors: guo c. Front Immunol. 2022 Sep 9;13:951529. doi: 10.3389/fimmu.2022.951529. eCollection 2022. Front Immunol. 2022. PMID: 36159831 Free PMC article.
58 results